If enacted, HB7184 will impose strict penalties on individuals and companies involved in the manufacture, distribution, or importation of equipment intended for the illegal production of drugs. Specifically, it will enhance legal repercussions for violations related to controlled substances, including significant prison sentences of up to 20 years for severe violations. This change aims to deter not only domestic operations but also international suppliers who may contribute to the influx of counterfeit substances within U.S. borders. As a result, the bill could reduce the availability of these harmful substances and promote public health and safety.
Summary
House Bill 7184, known as the Preventing Rogue Equipment for Synthetic Substances Act (PRESS Act), seeks to amend the Controlled Substances Act. The primary objective is to prohibit the importation of various types of equipment, specifically pill presses and encapsulating machines, that can be used for the illegal manufacturing of controlled substances. This bill addresses the growing concern over counterfeit drugs and the illicit production of synthetic opioids, which has been a significant factor in the ongoing opioid crisis throughout the nation. The bill emphasizes extraterritorial jurisdiction, allowing the United States to enforce regulations against foreign entities manufacturing equipment intended for illegal drug production.
Contention
Notable points of contention surrounding the bill may arise from concerns regarding its potential implications for legitimate manufacturers and businesses that produce similar equipment for lawful purposes, such as in pharmaceuticals or dietary supplements. Critics might argue that the broad language utilized in defining illicit devices could unintentionally criminalize certain business operations and lead to legal ambiguities. Additionally, there could be debates over the extent of extraterritorial jurisdiction and its implications for international trade relations, particularly with countries where such manufacturing practices are prevalent.
Halt All Lethal Trafficking of Fentanyl Act or the HALT Fentanyl Act This bill places fentanyl-related substances as a class into schedule I of the Controlled Substances Act. A schedule I controlled substance is a drug, substance, or chemical that has a high potential for abuse; has no currently accepted medical value; and is subject to regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act. Additionally, the bill establishes a new, alternative registration process for schedule I research that is funded by the Department of Health and Human Services or the Department of Veterans Affairs or that is conducted under an investigative new drug exemption from the Food and Drug Administration. The bill also makes several other changes to registration requirements for conducting research with controlled substances, including permitting a single registration for related research sites in certain circumstances, waiving the requirement for a new inspection in certain situations, and allowing a registered researcher to perform certain manufacturing activities with small quantities of a substance without obtaining a manufacturing registration.
Revocation and licensing requirements established for violations of impaired driving laws involving substances other than alcohol, rulemaking authorized, and money appropriated.